L305-1643 Screening compound: 2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazin-3-one

L305-1643 Screening compound: 2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazin-3-one
L305-1643 Screening compound: 2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L305-1643
2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L305-1643

Molecular Formula

C21H29N3O4S2 (C21 H29 N3 O4 S2)

Compound Name

2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazin-3-one

IUPAC name

2-(azepane-1-carbonyl)-6-[(4-methylpiperidin-1-yl)sulfonyl]-34-dihydro-2H-14-benzothiazin-3-one

SMILES

CC(CC1)CCN1S(c(cc1)cc(N2)c1SC(C(N1CCCCCC1)=O)C2=O)(=O)=O

InChI

InChI=1S/C21H29N3O4S2/c1-15-8-12-24(13-9-15)30(27,28)16-6-7-18-17(14-16)22-20(25)19(29-18)21(26)23-10-4-2-3-5-11-23/h6-7,14-15,19H,2-5,8-13H2,1H3,(H,22,25)/t19-/m0/s1

InChI Key

UVOKPYJNIKOVOC-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27243252

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.290

Distribution Coefficient, logD

3.290

Water Solubility, LogSw

-3.78

Polar Surface Area

73.806

Acid Dissociation Constant (pKa)

11.02

Base Dissociation Constant (pKb)

-0.19

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.90

L305-1643 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L305-1643 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L305-1643?
Check Price and Availability of L305-1643, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L305-1643 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L305-1643
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L305-1643
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L305-1643 available by request